How should the clinical efficiency of oocyte cryopreservation be measured?
Clinical application of oocyte cryopreservation may be in the context of fertility preservation for women about to undergo cytotoxic therapies or may be as an alternative to embryo cryopreservation in routine assisted reproduction. The clinical efficiency of oocyte cryopreservation will be a consequence of the cumulative impact of pre-freeze oocyte quality, postthaw survival and subcellular effects of cryopreservation protocols, which impact on early embryo quality and post-transfer viability, together with the degree of selection which is applied to the available biological material. Any valid assessment must include reference to all the above aspects, particularly when comparing cryopreserved oocytes with non-frozen controls or cryopreserved embryos. Cumulative pregnancy rates from oocyte collections may provide the most relevant index of success. Survival of human oocytes cryopreserved using current methodology is similar to that achieved with early-cleavage-stage embryos. Although evidence suggests that developmental potential may be compromised when current oocyte cryopreservation protocols are applied, there is a paucity of rigorously controlled studies in the literature.
Edgar
David H
DH
Reproductive Services/Melbourne IVF, Royal Women's Hospital, Carlton, Victoria 3053, Australia. david@mivf.com.au
Gook
Debra A
DA
D000328:Adult; D015925:Cryopreservation / Q000379:methods*; D010064:Embryo Implantation; D004622:Embryo, Mammalian / Q000378:metabolism; D005260:Female; D005298:Fertility; D005615:Freezing; D006801:Humans; D007246:Infertility / Q000628:therapy*; D008297:Male; D009865:Oocytes / Q000166:cytology* / Q000378:metabolism; D011247:Pregnancy; D011256:Pregnancy Outcome; D013997:Time Factors; D016896:Treatment Outcome